Haaartland

Login
FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key

inBrighter #Type1diabetes

FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key

Source: ENDPOINTS NEWS

Bo

Bo

Your sidekick
Sweden

Bo
Your sidekick

  • 0

In assessing Novo Nordisk's GLP-1 diabetes drug semaglutide for an upcoming panel review, insiders at the FDA nodded over the way researchers handled a few select challenges, offering an 'A' on efficacy and (mostly) safety as the experts prepped for their meeting on Wednesday. There will be close attention to

View original